tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Takeda and Protagonist Report Positive Phase 3 Results for Rusfertide in Polycythemia Vera
Company AnnouncementsTakeda and Protagonist Report Positive Phase 3 Results for Rusfertide in Polycythemia Vera
3d ago
Takeda Updates on Share Repurchase Progress
PremiumCompany Announcements
Takeda Updates on Share Repurchase Progress
3d ago
Takeda announces EMA approval for Takhzyro two mL pre-filled pen option
PremiumThe Fly
Takeda announces EMA approval for Takhzyro two mL pre-filled pen option
10d ago
TAK
Takeda CEO Christophe Weber to retire in 2026, Julie Kim to succeed
PremiumThe Fly
Takeda CEO Christophe Weber to retire in 2026, Julie Kim to succeed
1M ago
TAK
Takeda Names Julie Kim as Successor to CEO Christophe Weber
PremiumCompany Announcements
Takeda Names Julie Kim as Successor to CEO Christophe Weber
1M ago
Takeda Discontinues Soticlestat Development After Unsuccessful Trials
PremiumCompany AnnouncementsTakeda Discontinues Soticlestat Development After Unsuccessful Trials
1M ago
Takeda Announces Strategic Share Buyback to Boost Capital Efficiency
Premium
Company Announcements
Takeda Announces Strategic Share Buyback to Boost Capital Efficiency
1M ago
Takeda Revises FY2024 Financial Forecast with Significant Profit Increases
Premium
Company Announcements
Takeda Revises FY2024 Financial Forecast with Significant Profit Increases
1M ago
Takeda Reports Robust Nine-Month Financial Performance and Positive Outlook
PremiumCompany Announcements
Takeda Reports Robust Nine-Month Financial Performance and Positive Outlook
1M ago
Takeda Pharmaceutical Co (TKPHF) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Takeda Pharmaceutical Co (TKPHF) Q3 Earnings Cheat Sheet
1M ago
Neurocrine announces amendment to collaboration with Takeda
PremiumThe Fly
Neurocrine announces amendment to collaboration with Takeda
1M ago
TAK
NBIX
Avadel names Sev Melkonian as VP, patient services, distribution, reimbursement
PremiumThe Fly
Avadel names Sev Melkonian as VP, patient services, distribution, reimbursement
1M ago
TAK
AVDL
Keros Therapeutics announces effectiveness of global agreement with Takeda
PremiumThe FlyKeros Therapeutics announces effectiveness of global agreement with Takeda
1M ago
TAK
KROS
Keros Therapeutics price target lowered to $41 from $44 at Scotiabank
Premium
The Fly
Keros Therapeutics price target lowered to $41 from $44 at Scotiabank
2M ago
TAK
KROS
Halozyme announces Takeda receives approval for HYQVIA by MHLW
Premium
The Fly
Halozyme announces Takeda receives approval for HYQVIA by MHLW
2M ago
TAK
HALO
Takeda announces Japan MHLW approval for new Hyqvia use
PremiumThe Fly
Takeda announces Japan MHLW approval for new Hyqvia use
2M ago
TAK
Keros Therapeutics price target lowered to $43 from $100 at Truist
PremiumThe Fly
Keros Therapeutics price target lowered to $43 from $100 at Truist
2M ago
TAK
KROS
Hutchmed to receive milestone payment from Takeda
PremiumThe Fly
Hutchmed to receive milestone payment from Takeda
3M ago
HCM
TAK
Takeda Eyes Growth with Late-Stage Pipeline
PremiumCompany Announcements
Takeda Eyes Growth with Late-Stage Pipeline
3M ago
Takeda, Keros Therapeutics enter exclusive elritercept license agreement
PremiumThe FlyTakeda, Keros Therapeutics enter exclusive elritercept license agreement
3M ago
TAK
KROS
Keros Therapeutics announces global license agreement with Takeda
Premium
The Fly
Keros Therapeutics announces global license agreement with Takeda
3M ago
TAK
KROS
Takeda Shows Strong Growth and Raises Guidance
Premium
Company Announcements
Takeda Shows Strong Growth and Raises Guidance
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >